-
Moderna Says It Hopes to Offer New Vaccines for Cancer, Heart Disease, and Other Conditions by 2030
Moderna’s chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new vaccines.
-
Moderna Sues Pfizer, BioNTech Over Patent Behind COVID-19 Vaccine
The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.
-
Moderna Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID Vaccine
Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.
-
Moderna Asks FDA to Authorize Its Updated Covid Booster Shot
Moderna said Tuesday it had asked the Food and Drug Administration to authorize an updated version of its Covid booster shot.
-
US to Buy Moderna's Omicron COVID-19 Vaccine, Plans to Offer Updated Boosters in September
The Biden administration says it has reached an agreement with Moderna to buy 66 million doses of the company’s next generation of COVID-19 vaccine targeting the highly transmissible omicron variant.
-
FDA Advisers Approve Pfizer, Moderna Vaccines for Kids 6 Months to 5 Years Old
Alyssa Allen and her family of four have waited patiently for this moment. The FDA began to green-light the COVID-19 vaccine for infants, toddlers and children five and under. Allen’s daughter Hallie is 3 years old, the only one in the family not protected. “The big word is ‘finally,’ my family has been waiting what feels like forever to get…
-
Vaccines for Kids Under 5 Closer to Final Approval
NBC 6’s Marissa Bagg has details on the FDA panel vote authorizing vaccines for kids under 5 and the next step that follows
-
FDA Advisers Endorse Moderna, Pfizer COVID-19 Shots for Kids Under 5
The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.
-
FDA Advisers Endorse Moderna, Pfizer COVID-19 Shots for Kids as Young as 6 Months
COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.
-
FDA Advisers Back Moderna's COVID-19 Vaccine for Older Kids
A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17. A vaccine made by Pfizer has been available since last year for those ages. The Food and Drug...
-
Moderna Asks FDA to Authorize Its COVID Vaccine for Kids Under 6
Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect children under the age of 6.
-
Moderna Asks FDA to Approve Its COVID-19 Shot for Kids Under 6
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
-
Moderna Says Redesigned Covid Vaccine Produced Stronger Immunity Against Omicron Than Current Shots
A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.
-
COVID Second Booster: Here's What to Know About Who's Eligible, Who Can Wait
Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.
-
Moderna Says Its Low-Dose COVID Shots Work for Kids Under 6
Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers
-
Moderna Asks FDA to Authorize Second Booster Shot for All Adults
The request comes two days after Pfizer asked the Food and Drug Administration to authorize a second booster shot for adults 65 and older.
-
Moderna Seeks FDA Authorization for 4th Dose of COVID Shot
Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults
-
FDA Gives Moderna Full Approval for Its COVID-19 Vaccine
Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness
-
Moderna Launches Clinical Trial of Its mRNA HIV Vaccine
Nearly 60 participants were given their first doses of the experimental HIV vaccine Thursday
-
Moderna Testing Omicron-Specific Booster
Moderna is testing an omicron-specific COVID-19 vaccine booster.